| 221.16 0.44 (0.2%) | 11-13 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 261.86 | 1-year : | 305.85 |
| Resists | First : | 224.19 | Second : | 261.86 |
| Pivot price | 219.49 |
|||
| Supports | First : | 216.01 | Second : | 210.96 |
| MAs | MA(5) : | 221.27 |
MA(20) : | 218.65 |
| MA(100) : | 215.49 |
MA(250) : | 204.31 |
|
| MACD | MACD : | 1.8  |
Signal : | 1.6 |
| %K %D | K(14,3) : | 71.5 |
D(3) : | 71.5 |
| RSI | RSI(14): 57.3 |
|||
| 52-week | High : | 224.19 | Low : | 179.24 |
Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.[ RSP ] has closed below upper band by 30.3%. Bollinger Bands are 10% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 222.03 - 223.1 | 223.1 - 224.03 |
| Low: | 216.83 - 218.08 | 218.08 - 219.17 |
| Close: | 219.29 - 221.23 | 221.23 - 222.9 |
The Invesco S&P 500 Equal Weight ETF, known by its ticker RSP, aims to replicate the performance of the S&P 500 Equal Weight Index. The fund commits to allocating a minimum of 90% of its overall assets to the component securities of this underlying index.
Sat, 14 Nov 2026
Better Biotech ETF: First Trust's FBT vs. Invesco's PBE - The Motley Fool
Sat, 14 Nov 2026
Form 4 Invesco Unit Trusts For: 14 November By Investing.com - Investing.com Australia
Fri, 13 Nov 2026
Is Invesco (IVZ) Below Fair Value After Its ETF Push? - Yahoo Finance
Fri, 13 Nov 2026
Invesco (IVZ) Stock May Be 44% Undervalued As New ETFs Launch - Simply Wall St
Thu, 12 Nov 2026
China welcomes deeper investment cooperation with Invesco, vice premier says - The Standard (HK)
Wed, 11 Nov 2026
Is Invesco S&P 500 Equal Weight Health Care ETF (RSPH) a Strong ETF Right Now? - Yahoo Finance
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
AMEX
|
|
|
Sector:
Financial Services
|
|
|
Industry:
Asset Management
|
|
| Shares Out | 0 (M) |
| Shares Float | 0 (M) |
| Held by Insiders | 0 (%) |
| Held by Institutions | 0 (%) |
| Shares Short | 0 (K) |
| Shares Short P.Month | 0 (K) |
| EPS | 0 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | 0 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | 0 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 0 (M) |
| Levered Free Cash Flow | 0 (M) |
| PE Ratio | 0 |
| PEG Ratio | 0 |
| Price to Book value | 0 |
| Price to Sales | 0 |
| Price to Cash Flow | 0 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|